Richard Jackson
Concepts (467)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Protein Biosynthesis | 18 | 2012 | 273 | 3.380 |
Why?
| RNA, Viral | 13 | 2013 | 141 | 2.520 |
Why?
| Ribosomes | 12 | 2013 | 33 | 1.890 |
Why?
| Public Health | 8 | 2024 | 206 | 1.870 |
Why?
| Peptide Chain Initiation, Translational | 10 | 2013 | 15 | 1.530 |
Why?
| Polypyrimidine Tract-Binding Protein | 7 | 2014 | 10 | 1.510 |
Why?
| RNA, Messenger | 10 | 2014 | 1202 | 1.500 |
Why?
| Environment Design | 8 | 2024 | 25 | 1.240 |
Why?
| Rhinovirus | 3 | 2010 | 26 | 0.930 |
Why?
| Public Policy | 3 | 2015 | 40 | 0.850 |
Why?
| Nucleic Acid Conformation | 12 | 2013 | 99 | 0.810 |
Why?
| Environmental Health | 3 | 2011 | 12 | 0.760 |
Why?
| RNA-Binding Proteins | 5 | 2012 | 136 | 0.680 |
Why?
| City Planning | 5 | 2009 | 6 | 0.660 |
Why?
| Environment | 2 | 2011 | 103 | 0.650 |
Why?
| Ligaments | 1 | 2017 | 15 | 0.630 |
Why?
| Ribs | 1 | 2017 | 18 | 0.630 |
Why?
| Chest Pain | 1 | 2017 | 65 | 0.610 |
Why?
| Binding Sites | 10 | 2014 | 440 | 0.610 |
Why?
| Peptide Chain Termination, Translational | 4 | 2011 | 4 | 0.600 |
Why?
| MicroRNAs | 4 | 2011 | 386 | 0.580 |
Why?
| Vinblastine | 1 | 2017 | 41 | 0.580 |
Why?
| Gene Expression Regulation | 4 | 2011 | 1062 | 0.570 |
Why?
| Carcinoma, Transitional Cell | 1 | 2017 | 54 | 0.560 |
Why?
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 87 | 0.560 |
Why?
| Encephalomyocarditis virus | 3 | 2011 | 3 | 0.550 |
Why?
| Renewable Energy | 1 | 2015 | 1 | 0.540 |
Why?
| Biofuels | 1 | 2015 | 4 | 0.530 |
Why?
| Vertebrates | 2 | 2013 | 11 | 0.530 |
Why?
| Humans | 63 | 2024 | 54284 | 0.530 |
Why?
| Urinary Bladder Neoplasms | 1 | 2017 | 173 | 0.520 |
Why?
| Base Sequence | 12 | 2011 | 719 | 0.510 |
Why?
| Picornaviridae | 2 | 2011 | 2 | 0.510 |
Why?
| Eukaryotic Cells | 2 | 2012 | 20 | 0.500 |
Why?
| DNA-Binding Proteins | 3 | 2007 | 462 | 0.490 |
Why?
| Molecular Sequence Data | 11 | 2011 | 980 | 0.470 |
Why?
| Open Reading Frames | 5 | 2012 | 55 | 0.470 |
Why?
| Public Health Administration | 2 | 2012 | 84 | 0.460 |
Why?
| 5' Untranslated Regions | 4 | 2011 | 33 | 0.460 |
Why?
| Viral Proteins | 4 | 2009 | 158 | 0.450 |
Why?
| Eukaryotic Initiation Factors | 2 | 2010 | 5 | 0.450 |
Why?
| Eukaryotic Initiation Factor-4G | 2 | 2010 | 4 | 0.450 |
Why?
| Codon, Initiator | 7 | 2011 | 9 | 0.420 |
Why?
| Foot-and-Mouth Disease Virus | 1 | 2011 | 1 | 0.410 |
Why?
| Social Environment | 2 | 2012 | 96 | 0.400 |
Why?
| Poliovirus | 1 | 2010 | 9 | 0.390 |
Why?
| Eukaryota | 1 | 2010 | 10 | 0.370 |
Why?
| Health Policy | 1 | 2011 | 171 | 0.360 |
Why?
| Pancreatic Neoplasms | 2 | 2022 | 234 | 0.350 |
Why?
| Obesity | 2 | 2011 | 1202 | 0.340 |
Why?
| Virus Replication | 1 | 2010 | 143 | 0.340 |
Why?
| Social Conditions | 1 | 2008 | 7 | 0.320 |
Why?
| Residence Characteristics | 2 | 2024 | 166 | 0.320 |
Why?
| Calicivirus, Feline | 1 | 2007 | 2 | 0.320 |
Why?
| RNA Caps | 1 | 2007 | 10 | 0.310 |
Why?
| Models, Genetic | 2 | 2007 | 209 | 0.310 |
Why?
| Research | 2 | 2005 | 110 | 0.300 |
Why?
| Peptic Ulcer Perforation | 1 | 2006 | 5 | 0.300 |
Why?
| Abdomen, Acute | 1 | 2006 | 6 | 0.300 |
Why?
| Stomach Ulcer | 1 | 2006 | 6 | 0.300 |
Why?
| Urban Health | 2 | 2003 | 36 | 0.300 |
Why?
| Life Style | 1 | 2008 | 156 | 0.290 |
Why?
| Animals | 20 | 2013 | 14385 | 0.290 |
Why?
| Adolescent | 15 | 2017 | 6897 | 0.290 |
Why?
| Community Health Planning | 2 | 2003 | 30 | 0.290 |
Why?
| Gastroenteritis | 1 | 2006 | 20 | 0.290 |
Why?
| Protein Structure, Tertiary | 4 | 2014 | 289 | 0.290 |
Why?
| United States | 11 | 2015 | 5217 | 0.290 |
Why?
| Gastrointestinal Diseases | 2 | 2008 | 126 | 0.290 |
Why?
| Health Promotion | 4 | 2013 | 300 | 0.280 |
Why?
| Eosinophilia | 1 | 2006 | 39 | 0.280 |
Why?
| Bacterial Translocation | 4 | 2009 | 23 | 0.270 |
Why?
| Genes, Neurofibromatosis 1 | 1 | 2005 | 3 | 0.270 |
Why?
| Neurofibromatoses | 1 | 2005 | 6 | 0.260 |
Why?
| Mental Health | 1 | 2008 | 245 | 0.260 |
Why?
| Nerve Sheath Neoplasms | 1 | 2005 | 23 | 0.260 |
Why?
| Laparoscopy | 4 | 2013 | 188 | 0.260 |
Why?
| Rectal Neoplasms | 1 | 2005 | 51 | 0.250 |
Why?
| Probiotics | 3 | 2009 | 32 | 0.250 |
Why?
| Child | 19 | 2017 | 7341 | 0.240 |
Why?
| Mammals | 3 | 2010 | 57 | 0.240 |
Why?
| Rain | 1 | 2003 | 6 | 0.240 |
Why?
| Water Pollutants | 1 | 2003 | 8 | 0.240 |
Why?
| Water Supply | 1 | 2003 | 21 | 0.240 |
Why?
| Water Microbiology | 1 | 2003 | 25 | 0.240 |
Why?
| Public Health Practice | 1 | 2003 | 43 | 0.230 |
Why?
| Pestivirus | 1 | 2002 | 1 | 0.230 |
Why?
| Regulatory Sequences, Ribonucleic Acid | 1 | 2002 | 6 | 0.230 |
Why?
| Retrospective Studies | 13 | 2017 | 6432 | 0.220 |
Why?
| Cryogels | 1 | 2022 | 1 | 0.220 |
Why?
| Carcinoma, Pancreatic Ductal | 1 | 2022 | 35 | 0.210 |
Why?
| Goiter, Endemic | 1 | 2002 | 1 | 0.210 |
Why?
| Nuclear Reactors | 1 | 2002 | 2 | 0.210 |
Why?
| Iodine | 1 | 2002 | 12 | 0.210 |
Why?
| Radioactive Hazard Release | 1 | 2002 | 16 | 0.210 |
Why?
| Exercise | 2 | 2015 | 552 | 0.210 |
Why?
| Child, Preschool | 13 | 2017 | 4147 | 0.210 |
Why?
| Neoplasms, Radiation-Induced | 1 | 2002 | 42 | 0.210 |
Why?
| Sodium Chloride, Dietary | 1 | 2002 | 33 | 0.210 |
Why?
| Rectum | 2 | 2017 | 51 | 0.210 |
Why?
| Male | 24 | 2017 | 27334 | 0.200 |
Why?
| Genetic Predisposition to Disease | 1 | 2005 | 570 | 0.200 |
Why?
| Fundoplication | 2 | 2013 | 21 | 0.200 |
Why?
| Disaster Planning | 1 | 2002 | 57 | 0.200 |
Why?
| Aortic Aneurysm, Abdominal | 1 | 2021 | 56 | 0.200 |
Why?
| Hyperthermia, Induced | 1 | 2022 | 107 | 0.200 |
Why?
| Female | 23 | 2017 | 28441 | 0.190 |
Why?
| Computer Simulation | 1 | 2021 | 332 | 0.190 |
Why?
| Models, Molecular | 3 | 2012 | 423 | 0.190 |
Why?
| Influenza B virus | 2 | 2011 | 6 | 0.180 |
Why?
| Environmental Exposure | 1 | 2002 | 205 | 0.180 |
Why?
| Treatment Outcome | 11 | 2021 | 5604 | 0.180 |
Why?
| Blood Vessel Prosthesis Implantation | 1 | 2021 | 129 | 0.180 |
Why?
| Reticulocytes | 3 | 2011 | 14 | 0.180 |
Why?
| Codon | 2 | 2010 | 48 | 0.170 |
Why?
| Rabbits | 7 | 2011 | 425 | 0.170 |
Why?
| Pyloric Stenosis | 2 | 2009 | 8 | 0.170 |
Why?
| Genome, Viral | 2 | 2011 | 100 | 0.170 |
Why?
| Endovascular Procedures | 1 | 2021 | 186 | 0.170 |
Why?
| Diabetes Mellitus | 1 | 2022 | 309 | 0.160 |
Why?
| Sequence Alignment | 2 | 2009 | 146 | 0.160 |
Why?
| Amino Acid Sequence | 3 | 2009 | 767 | 0.150 |
Why?
| Ireland | 1 | 2017 | 11 | 0.150 |
Why?
| Vagina | 1 | 2017 | 47 | 0.150 |
Why?
| Urothelium | 1 | 2017 | 23 | 0.150 |
Why?
| Syndrome | 1 | 2017 | 252 | 0.150 |
Why?
| Lasers, Solid-State | 1 | 2017 | 32 | 0.150 |
Why?
| Alternative Splicing | 2 | 2014 | 64 | 0.150 |
Why?
| Walking | 2 | 2015 | 110 | 0.140 |
Why?
| Wounds, Nonpenetrating | 2 | 2008 | 91 | 0.140 |
Why?
| Infant | 11 | 2017 | 3817 | 0.140 |
Why?
| Disease-Free Survival | 1 | 2017 | 485 | 0.140 |
Why?
| Cohort Studies | 6 | 2022 | 1543 | 0.130 |
Why?
| Food, Formulated | 2 | 2008 | 44 | 0.130 |
Why?
| Vascular Malformations | 1 | 2017 | 101 | 0.130 |
Why?
| Catheterization | 2 | 2008 | 108 | 0.130 |
Why?
| Public Opinion | 1 | 2015 | 20 | 0.130 |
Why?
| Postoperative Complications | 4 | 2021 | 1033 | 0.130 |
Why?
| Bicycling | 1 | 2015 | 43 | 0.130 |
Why?
| Lung | 2 | 2009 | 507 | 0.130 |
Why?
| Bone Neoplasms | 1 | 2017 | 193 | 0.130 |
Why?
| RNA Precursors | 1 | 2014 | 11 | 0.130 |
Why?
| Codon, Terminator | 3 | 2009 | 8 | 0.120 |
Why?
| Enteral Nutrition | 3 | 2008 | 136 | 0.120 |
Why?
| Gastric Fistula | 1 | 2013 | 12 | 0.120 |
Why?
| Cutaneous Fistula | 1 | 2013 | 16 | 0.120 |
Why?
| Aged | 5 | 2022 | 10054 | 0.120 |
Why?
| Gastric Mucosa | 3 | 2009 | 59 | 0.120 |
Why?
| Gastrostomy | 1 | 2013 | 60 | 0.120 |
Why?
| Peptide Initiation Factors | 1 | 2013 | 3 | 0.110 |
Why?
| Communication | 1 | 2015 | 273 | 0.110 |
Why?
| Animals, Newborn | 3 | 2009 | 396 | 0.110 |
Why?
| Liver Neoplasms | 1 | 2017 | 352 | 0.110 |
Why?
| Mobility Limitation | 1 | 2012 | 25 | 0.110 |
Why?
| Local Government | 1 | 2012 | 25 | 0.100 |
Why?
| Protein Binding | 3 | 2014 | 736 | 0.100 |
Why?
| Kobuvirus | 1 | 2011 | 1 | 0.100 |
Why?
| Physician's Role | 2 | 2009 | 55 | 0.100 |
Why?
| Regulatory Elements, Transcriptional | 1 | 2011 | 8 | 0.100 |
Why?
| Chloramphenicol O-Acetyltransferase | 1 | 2011 | 10 | 0.100 |
Why?
| Mutation | 4 | 2014 | 1501 | 0.100 |
Why?
| Artificial Gene Fusion | 1 | 2011 | 13 | 0.100 |
Why?
| Adult | 8 | 2015 | 14207 | 0.100 |
Why?
| Enterobacter cloacae | 2 | 2009 | 8 | 0.100 |
Why?
| Middle Aged | 5 | 2022 | 13088 | 0.100 |
Why?
| Stomach | 3 | 2009 | 80 | 0.100 |
Why?
| HeLa Cells | 2 | 2010 | 291 | 0.100 |
Why?
| Genes, Reporter | 1 | 2011 | 98 | 0.100 |
Why?
| Poly A | 1 | 2011 | 14 | 0.100 |
Why?
| Organizational Objectives | 1 | 2011 | 36 | 0.100 |
Why?
| Life Expectancy | 1 | 2011 | 40 | 0.100 |
Why?
| Leadership | 1 | 2012 | 114 | 0.100 |
Why?
| Follow-Up Studies | 6 | 2017 | 2387 | 0.100 |
Why?
| Base Pairing | 1 | 2010 | 28 | 0.100 |
Why?
| Spleen | 2 | 2009 | 186 | 0.100 |
Why?
| Bromouracil | 1 | 2010 | 1 | 0.090 |
Why?
| Pseudouridine | 1 | 2010 | 1 | 0.090 |
Why?
| Infant, Newborn | 7 | 2010 | 2907 | 0.090 |
Why?
| Trinucleotide Repeats | 1 | 2010 | 3 | 0.090 |
Why?
| Uridine | 1 | 2010 | 6 | 0.090 |
Why?
| Uridine Triphosphate | 1 | 2010 | 13 | 0.090 |
Why?
| Cell Extracts | 1 | 2010 | 5 | 0.090 |
Why?
| Quality of Life | 2 | 2021 | 922 | 0.090 |
Why?
| Microtechnology | 1 | 2010 | 4 | 0.090 |
Why?
| Kinetics | 2 | 2010 | 692 | 0.090 |
Why?
| Laparotomy | 2 | 2008 | 36 | 0.090 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 79 | 0.090 |
Why?
| RNA, Small Interfering | 2 | 2011 | 252 | 0.090 |
Why?
| Hernia, Diaphragmatic | 1 | 2010 | 22 | 0.090 |
Why?
| Norovirus | 1 | 2009 | 4 | 0.090 |
Why?
| Meconium | 1 | 2009 | 5 | 0.090 |
Why?
| Enema | 1 | 2009 | 8 | 0.090 |
Why?
| Point Mutation | 1 | 2010 | 92 | 0.090 |
Why?
| Transportation | 2 | 2015 | 31 | 0.090 |
Why?
| Biopsy | 3 | 2009 | 692 | 0.090 |
Why?
| Ileus | 1 | 2009 | 16 | 0.090 |
Why?
| Intestinal Atresia | 1 | 2009 | 4 | 0.090 |
Why?
| Viruses | 1 | 2009 | 21 | 0.090 |
Why?
| Enterobacteriaceae Infections | 1 | 2009 | 18 | 0.090 |
Why?
| Food, Fortified | 1 | 2009 | 33 | 0.090 |
Why?
| Models, Educational | 1 | 2009 | 35 | 0.080 |
Why?
| Pyloric Stenosis, Hypertrophic | 1 | 2009 | 29 | 0.080 |
Why?
| Peritoneal Dialysis | 1 | 2008 | 37 | 0.080 |
Why?
| Risk Assessment | 4 | 2008 | 1361 | 0.080 |
Why?
| Models, Biological | 3 | 2008 | 823 | 0.080 |
Why?
| Suture Techniques | 1 | 2008 | 70 | 0.080 |
Why?
| Health Behavior | 2 | 2015 | 277 | 0.080 |
Why?
| Snake Bites | 1 | 2008 | 19 | 0.080 |
Why?
| Multiple Trauma | 1 | 2008 | 34 | 0.080 |
Why?
| Epithelial Cells | 1 | 2010 | 255 | 0.080 |
Why?
| Viral Structural Proteins | 1 | 2007 | 6 | 0.080 |
Why?
| Equipment Contamination | 3 | 2002 | 26 | 0.080 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2007 | 59 | 0.080 |
Why?
| Genes | 1 | 2007 | 38 | 0.080 |
Why?
| Cats | 1 | 2007 | 52 | 0.080 |
Why?
| RNA Cap Analogs | 1 | 2007 | 1 | 0.080 |
Why?
| Robotics | 1 | 2008 | 45 | 0.080 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2007 | 74 | 0.080 |
Why?
| Pheochromocytoma | 1 | 2008 | 38 | 0.080 |
Why?
| Drosophila | 1 | 2007 | 17 | 0.080 |
Why?
| Telephone | 1 | 2008 | 75 | 0.080 |
Why?
| Adrenal Gland Neoplasms | 1 | 2008 | 54 | 0.080 |
Why?
| Polymers | 2 | 2022 | 44 | 0.080 |
Why?
| Diagnosis, Differential | 3 | 2006 | 1136 | 0.080 |
Why?
| United States Government Agencies | 1 | 2007 | 3 | 0.080 |
Why?
| Intestinal Obstruction | 1 | 2007 | 37 | 0.080 |
Why?
| Ecology | 1 | 2007 | 15 | 0.080 |
Why?
| Endosonography | 1 | 2008 | 96 | 0.080 |
Why?
| Enzymes, Immobilized | 1 | 2007 | 4 | 0.080 |
Why?
| Aftercare | 1 | 2008 | 81 | 0.080 |
Why?
| Disulfides | 1 | 2007 | 15 | 0.080 |
Why?
| Eukaryotic Initiation Factor-4E | 1 | 2007 | 8 | 0.070 |
Why?
| Cystic Fibrosis | 1 | 2009 | 157 | 0.070 |
Why?
| Time Factors | 4 | 2010 | 3213 | 0.070 |
Why?
| Biosensing Techniques | 1 | 2007 | 28 | 0.070 |
Why?
| RNA Stability | 1 | 2007 | 28 | 0.070 |
Why?
| Surgical Procedures, Operative | 1 | 2008 | 78 | 0.070 |
Why?
| Child Welfare | 1 | 2007 | 73 | 0.070 |
Why?
| Duodenum | 1 | 2006 | 36 | 0.070 |
Why?
| Extracorporeal Membrane Oxygenation | 1 | 2010 | 302 | 0.070 |
Why?
| Hemodynamics | 1 | 2008 | 290 | 0.070 |
Why?
| Abdominal Injuries | 1 | 2006 | 34 | 0.070 |
Why?
| Aorta, Abdominal | 1 | 2006 | 45 | 0.070 |
Why?
| Lipoma | 1 | 2006 | 21 | 0.070 |
Why?
| Cell Line | 3 | 2008 | 1153 | 0.070 |
Why?
| Caenorhabditis elegans | 1 | 2007 | 146 | 0.070 |
Why?
| Glycoproteins | 1 | 2007 | 132 | 0.070 |
Why?
| Endoscopy, Gastrointestinal | 1 | 2006 | 75 | 0.070 |
Why?
| Aging | 1 | 2012 | 784 | 0.070 |
Why?
| RNA, Ribosomal, 18S | 3 | 2011 | 8 | 0.070 |
Why?
| Arterial Occlusive Diseases | 1 | 2006 | 92 | 0.070 |
Why?
| Curriculum | 1 | 2009 | 429 | 0.070 |
Why?
| Mesenchymoma | 1 | 2005 | 3 | 0.070 |
Why?
| Neuroectodermal Tumors, Primitive | 1 | 2005 | 4 | 0.070 |
Why?
| Gold | 1 | 2007 | 164 | 0.070 |
Why?
| Rhabdomyosarcoma | 1 | 2005 | 13 | 0.070 |
Why?
| Down-Regulation | 1 | 2007 | 388 | 0.070 |
Why?
| Clinical Competence | 1 | 2009 | 446 | 0.070 |
Why?
| Leiomyosarcoma | 1 | 2005 | 25 | 0.070 |
Why?
| Transcription, Genetic | 2 | 2003 | 418 | 0.060 |
Why?
| Prospective Studies | 4 | 2022 | 2604 | 0.060 |
Why?
| Liver | 2 | 2009 | 1225 | 0.060 |
Why?
| Aircraft | 1 | 2004 | 12 | 0.060 |
Why?
| Body Weight | 2 | 2004 | 578 | 0.060 |
Why?
| Ultrasonography | 4 | 2009 | 480 | 0.060 |
Why?
| Diet | 1 | 2009 | 598 | 0.060 |
Why?
| Play and Playthings | 1 | 2004 | 13 | 0.060 |
Why?
| Mutagenesis, Site-Directed | 1 | 2004 | 117 | 0.060 |
Why?
| Organothiophosphorus Compounds | 1 | 2004 | 6 | 0.060 |
Why?
| Costs and Cost Analysis | 1 | 2004 | 109 | 0.060 |
Why?
| Firearms | 1 | 2004 | 17 | 0.060 |
Why?
| Wounds, Gunshot | 1 | 2004 | 28 | 0.060 |
Why?
| Insecticides | 1 | 2004 | 19 | 0.060 |
Why?
| Water Movements | 1 | 2003 | 2 | 0.060 |
Why?
| Healthy People Programs | 1 | 2003 | 4 | 0.060 |
Why?
| Social Change | 1 | 2003 | 5 | 0.060 |
Why?
| Waste Disposal, Fluid | 1 | 2003 | 8 | 0.060 |
Why?
| Automobiles | 1 | 2003 | 16 | 0.060 |
Why?
| Rectal Diseases | 1 | 2003 | 9 | 0.060 |
Why?
| Eukaryotic Initiation Factor-4A | 1 | 2002 | 1 | 0.060 |
Why?
| Classical swine fever virus | 1 | 2002 | 2 | 0.060 |
Why?
| Structure-Activity Relationship | 1 | 2004 | 423 | 0.060 |
Why?
| Digestive System Surgical Procedures | 1 | 2003 | 35 | 0.060 |
Why?
| Prokaryotic Cells | 1 | 2002 | 8 | 0.060 |
Why?
| GATA6 Transcription Factor | 1 | 2022 | 3 | 0.060 |
Why?
| Gastroschisis | 1 | 2003 | 40 | 0.060 |
Why?
| GATA4 Transcription Factor | 1 | 2022 | 13 | 0.060 |
Why?
| Hydrochloric Acid | 1 | 2002 | 3 | 0.060 |
Why?
| Genetic Engineering | 1 | 2002 | 27 | 0.060 |
Why?
| Cost of Illness | 1 | 2003 | 133 | 0.060 |
Why?
| Disease Reservoirs | 1 | 2002 | 7 | 0.050 |
Why?
| Citric Acid | 1 | 2002 | 21 | 0.050 |
Why?
| Magnetic Phenomena | 1 | 2022 | 7 | 0.050 |
Why?
| Multicenter Studies as Topic | 1 | 2022 | 91 | 0.050 |
Why?
| Gels | 1 | 2022 | 19 | 0.050 |
Why?
| Risk Factors | 3 | 2021 | 3935 | 0.050 |
Why?
| Pancreas | 1 | 2022 | 80 | 0.050 |
Why?
| Fibrin | 1 | 2002 | 14 | 0.050 |
Why?
| Empyema | 1 | 2002 | 8 | 0.050 |
Why?
| Republic of Belarus | 1 | 2002 | 1 | 0.050 |
Why?
| Ukraine | 1 | 2002 | 5 | 0.050 |
Why?
| Length of Stay | 4 | 2008 | 683 | 0.050 |
Why?
| Russia | 1 | 2002 | 11 | 0.050 |
Why?
| Deficiency Diseases | 1 | 2002 | 16 | 0.050 |
Why?
| State Medicine | 1 | 2021 | 17 | 0.050 |
Why?
| Drug Resistance, Bacterial | 1 | 2002 | 81 | 0.050 |
Why?
| Reference Values | 3 | 2008 | 354 | 0.050 |
Why?
| Critical Pathways | 1 | 2002 | 36 | 0.050 |
Why?
| Hepacivirus | 1 | 2002 | 127 | 0.050 |
Why?
| Bacterial Infections | 1 | 2002 | 105 | 0.050 |
Why?
| Thyroid Gland | 1 | 2002 | 93 | 0.050 |
Why?
| Cross Infection | 1 | 2002 | 107 | 0.050 |
Why?
| Incidence | 3 | 2013 | 1082 | 0.050 |
Why?
| Sensitivity and Specificity | 3 | 2008 | 923 | 0.050 |
Why?
| Early Detection of Cancer | 1 | 2022 | 162 | 0.050 |
Why?
| Congenital Abnormalities | 1 | 2002 | 112 | 0.050 |
Why?
| Catheterization, Central Venous | 1 | 2002 | 98 | 0.050 |
Why?
| Intestines | 1 | 2002 | 204 | 0.050 |
Why?
| Smoking | 1 | 2005 | 556 | 0.050 |
Why?
| Proteins | 1 | 2003 | 376 | 0.040 |
Why?
| Thyroid Neoplasms | 1 | 2002 | 162 | 0.040 |
Why?
| RNA | 2 | 2012 | 202 | 0.040 |
Why?
| Sepsis | 1 | 2002 | 251 | 0.040 |
Why?
| Acetaminophen | 1 | 2022 | 349 | 0.040 |
Why?
| Mice | 4 | 2011 | 6413 | 0.040 |
Why?
| Radiography | 2 | 2009 | 524 | 0.040 |
Why?
| Probability | 2 | 2008 | 176 | 0.040 |
Why?
| Gene Expression Profiling | 1 | 2022 | 1138 | 0.040 |
Why?
| Arkansas | 3 | 2010 | 2100 | 0.040 |
Why?
| Intestinal Mucosa | 2 | 2009 | 259 | 0.040 |
Why?
| Young Adult | 2 | 2017 | 4318 | 0.030 |
Why?
| Injury Severity Score | 2 | 2008 | 178 | 0.030 |
Why?
| Colon | 2 | 2009 | 110 | 0.030 |
Why?
| Models, Animal | 2 | 2009 | 255 | 0.030 |
Why?
| Los Angeles | 1 | 2015 | 25 | 0.030 |
Why?
| Cross-Sectional Studies | 2 | 2015 | 1693 | 0.030 |
Why?
| Reoperation | 2 | 2008 | 454 | 0.030 |
Why?
| Sex Factors | 2 | 2008 | 767 | 0.030 |
Why?
| Data Collection | 1 | 2015 | 321 | 0.030 |
Why?
| ROC Curve | 1 | 2013 | 259 | 0.030 |
Why?
| Disease Models, Animal | 2 | 2009 | 1639 | 0.030 |
Why?
| Staphylococcus epidermidis | 2 | 2002 | 16 | 0.030 |
Why?
| Planning Techniques | 1 | 2012 | 12 | 0.030 |
Why?
| Age Factors | 2 | 2008 | 1198 | 0.030 |
Why?
| Exons | 1 | 2012 | 105 | 0.030 |
Why?
| Automobile Driving | 1 | 2012 | 30 | 0.030 |
Why?
| California | 1 | 2012 | 90 | 0.030 |
Why?
| Health Plan Implementation | 1 | 2012 | 41 | 0.030 |
Why?
| Gene Expression Regulation, Viral | 1 | 2011 | 50 | 0.030 |
Why?
| Social Class | 1 | 2012 | 110 | 0.030 |
Why?
| Micrococcal Nuclease | 1 | 2011 | 7 | 0.030 |
Why?
| RNA-Induced Silencing Complex | 1 | 2011 | 2 | 0.030 |
Why?
| Eukaryotic Initiation Factor-3 | 1 | 2011 | 1 | 0.030 |
Why?
| RNA, Ribosomal | 1 | 2011 | 18 | 0.020 |
Why?
| Oligonucleotides, Antisense | 1 | 2011 | 29 | 0.020 |
Why?
| Nucleotide Motifs | 1 | 2011 | 29 | 0.020 |
Why?
| Oligonucleotides | 1 | 2011 | 76 | 0.020 |
Why?
| Logistic Models | 1 | 2013 | 995 | 0.020 |
Why?
| Silicon | 1 | 2010 | 8 | 0.020 |
Why?
| Immunoassay | 1 | 2010 | 31 | 0.020 |
Why?
| Edeine | 1 | 2009 | 1 | 0.020 |
Why?
| RNA, Complementary | 1 | 2009 | 4 | 0.020 |
Why?
| 5' Flanking Region | 1 | 2009 | 6 | 0.020 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 543 | 0.020 |
Why?
| Diatrizoate Meglumine | 1 | 2009 | 4 | 0.020 |
Why?
| Nucleotides | 1 | 2009 | 23 | 0.020 |
Why?
| Luciferases | 1 | 2009 | 57 | 0.020 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2009 | 41 | 0.020 |
Why?
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 18 | 0.020 |
Why?
| Hirschsprung Disease | 1 | 2009 | 3 | 0.020 |
Why?
| DNA, Single-Stranded | 1 | 2010 | 73 | 0.020 |
Why?
| Saccharomyces cerevisiae | 1 | 2011 | 218 | 0.020 |
Why?
| Chronic Disease | 1 | 2012 | 614 | 0.020 |
Why?
| Anastomosis, Surgical | 1 | 2009 | 72 | 0.020 |
Why?
| Birth Weight | 1 | 2009 | 126 | 0.020 |
Why?
| Staff Development | 1 | 2009 | 26 | 0.020 |
Why?
| Models, Theoretical | 1 | 2010 | 184 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 2009 | 194 | 0.020 |
Why?
| Cecum | 1 | 2009 | 72 | 0.020 |
Why?
| Peritonitis | 1 | 2008 | 33 | 0.020 |
Why?
| Physical Examination | 1 | 2009 | 99 | 0.020 |
Why?
| Foreign-Body Migration | 1 | 2008 | 28 | 0.020 |
Why?
| Pelvis | 1 | 2008 | 76 | 0.020 |
Why?
| Phenoxybenzamine | 1 | 2008 | 16 | 0.020 |
Why?
| Preoperative Care | 1 | 2009 | 184 | 0.020 |
Why?
| Sickness Impact Profile | 1 | 2008 | 36 | 0.020 |
Why?
| Host-Pathogen Interactions | 1 | 2009 | 143 | 0.020 |
Why?
| Adrenalectomy | 1 | 2008 | 33 | 0.020 |
Why?
| Radiography, Abdominal | 1 | 2008 | 29 | 0.020 |
Why?
| Intestinal Volvulus | 1 | 2007 | 7 | 0.020 |
Why?
| Survival Analysis | 1 | 2010 | 735 | 0.020 |
Why?
| Colony Count, Microbial | 1 | 2008 | 66 | 0.020 |
Why?
| Interprofessional Relations | 1 | 2009 | 97 | 0.020 |
Why?
| Sex Distribution | 1 | 2008 | 158 | 0.020 |
Why?
| Age Distribution | 1 | 2008 | 198 | 0.020 |
Why?
| Neurosurgery | 1 | 2008 | 34 | 0.020 |
Why?
| Gestational Age | 1 | 2009 | 435 | 0.020 |
Why?
| Phosphorylation | 1 | 2009 | 614 | 0.020 |
Why?
| DNA Primers | 1 | 2008 | 225 | 0.020 |
Why?
| Enterocolitis, Necrotizing | 1 | 2008 | 36 | 0.020 |
Why?
| General Surgery | 1 | 2009 | 113 | 0.020 |
Why?
| Nurse's Role | 1 | 2008 | 90 | 0.020 |
Why?
| Magnetic Resonance Imaging | 2 | 2006 | 1604 | 0.020 |
Why?
| Safety | 1 | 2008 | 92 | 0.020 |
Why?
| Biopsy, Needle | 1 | 2008 | 195 | 0.020 |
Why?
| Horseradish Peroxidase | 1 | 2007 | 23 | 0.020 |
Why?
| Random Allocation | 1 | 2008 | 312 | 0.020 |
Why?
| Postoperative Care | 1 | 2008 | 121 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2007 | 318 | 0.020 |
Why?
| Angioplasty | 1 | 2006 | 26 | 0.020 |
Why?
| Carbohydrates | 1 | 2007 | 64 | 0.020 |
Why?
| Lymph Nodes | 1 | 2009 | 284 | 0.020 |
Why?
| Kidney Failure, Chronic | 1 | 2008 | 231 | 0.020 |
Why?
| Hydrogen Peroxide | 1 | 2007 | 142 | 0.020 |
Why?
| Hospitals, Pediatric | 1 | 2008 | 272 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2008 | 692 | 0.020 |
Why?
| Registries | 1 | 2008 | 553 | 0.020 |
Why?
| Gene Expression | 1 | 2008 | 664 | 0.020 |
Why?
| Survival Rate | 1 | 2008 | 951 | 0.020 |
Why?
| Neoplasm Invasiveness | 1 | 2006 | 295 | 0.020 |
Why?
| Neoplasm Staging | 1 | 2008 | 806 | 0.020 |
Why?
| Practice Guidelines as Topic | 1 | 2008 | 492 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2009 | 1304 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2008 | 1089 | 0.020 |
Why?
| Case-Control Studies | 1 | 2008 | 1228 | 0.020 |
Why?
| Glucose | 1 | 2007 | 366 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2008 | 1084 | 0.020 |
Why?
| Health Priorities | 1 | 2003 | 19 | 0.010 |
Why?
| Rectal Fistula | 1 | 2003 | 1 | 0.010 |
Why?
| Tissue Distribution | 1 | 2004 | 178 | 0.010 |
Why?
| Environmental Pollution | 1 | 2003 | 11 | 0.010 |
Why?
| Creatinine | 1 | 2004 | 169 | 0.010 |
Why?
| Algorithms | 1 | 2007 | 697 | 0.010 |
Why?
| Congresses as Topic | 1 | 2003 | 52 | 0.010 |
Why?
| Housing | 1 | 2003 | 48 | 0.010 |
Why?
| Compartment Syndromes | 1 | 2003 | 18 | 0.010 |
Why?
| Apoptotic Protease-Activating Factor 1 | 1 | 2003 | 1 | 0.010 |
Why?
| Ultraviolet Rays | 1 | 2003 | 56 | 0.010 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 124 | 0.010 |
Why?
| Cysts | 1 | 2003 | 50 | 0.010 |
Why?
| Mutagenesis | 1 | 2003 | 77 | 0.010 |
Why?
| Internship and Residency | 1 | 2009 | 501 | 0.010 |
Why?
| Enterobacter | 1 | 2002 | 7 | 0.010 |
Why?
| Enterococcus | 1 | 2002 | 11 | 0.010 |
Why?
| Vancomycin Resistance | 1 | 2002 | 8 | 0.010 |
Why?
| Methicillin Resistance | 1 | 2002 | 25 | 0.010 |
Why?
| Food Contamination | 1 | 2002 | 42 | 0.010 |
Why?
| Disease Transmission, Infectious | 1 | 2002 | 19 | 0.010 |
Why?
| Protein Conformation | 1 | 2003 | 226 | 0.010 |
Why?
| Bacterial Adhesion | 1 | 2002 | 20 | 0.010 |
Why?
| Thoracostomy | 1 | 2002 | 12 | 0.010 |
Why?
| Transfection | 1 | 2003 | 399 | 0.010 |
Why?
| Thoracic Surgery, Video-Assisted | 1 | 2002 | 11 | 0.010 |
Why?
| Neoplasm Recurrence, Local | 1 | 2006 | 644 | 0.010 |
Why?
| Gene Deletion | 1 | 2003 | 293 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 2003 | 531 | 0.010 |
Why?
| Blotting, Western | 1 | 2003 | 683 | 0.010 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 673 | 0.010 |
Why?
| Health Status | 1 | 2003 | 368 | 0.010 |
Why?
| Equipment Design | 1 | 2002 | 318 | 0.010 |
Why?
| Tomography, X-Ray Computed | 1 | 2006 | 1213 | 0.010 |
Why?
| Phenotype | 1 | 2003 | 820 | 0.010 |
Why?
| Neurons | 1 | 2003 | 486 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2003 | 1476 | 0.010 |
Why?
| Staphylococcus aureus | 1 | 2002 | 361 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2002 | 1663 | 0.010 |
Why?
| Rats | 1 | 2002 | 3415 | 0.010 |
Why?
|
|
Jackson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|